Navigation Links
Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Date:4/27/2009

estimated euro 76.7 billion by 2050.

Wyeth intends to introduce CONBRIZA in certain European markets following receipt of necessary reimbursement authorizations in those markets. Wyeth is also pursuing regulatory approval of bazedoxifene for the prevention and treatment of postmenopausal osteoporosis in the United States and other countries worldwide.

CONBRIZA Clinical Trials

The efficacy of CONBRIZA was studied in two multicenter, double-blind, randomized phase 3 clinical trials involving more than 9,000 postmenopausal women, comparing CONBRIZA to placebo and an active-control (comparator) drug. The prevention trial, conducted for two years in 1,583 patients, evaluated bone mineral density; and the treatment trial examined the incidence of new vertebral fractures in 7,492 patients for three years. Data from these studies indicated that the SERM characteristics of CONBRIZA were confirmed and further suggest a favorable endometrial profile. The most serious adverse reactions reported with CONBRIZA in these studies were venous thromboembolic events, which were more common than with placebo.

About Wyeth Pharmaceuticals

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In particular, there can be no assurance that CONBRIZA will b
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
2. $52.5 Million Settlement Against Sepracor Inc. Approved
3. FDA Cracks Down on Unapproved Cough Medicines
4. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
5. Optometry-Backed Vision Care for Kids Act Approved by U.S. House
6. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
7. A fresh look at existing therapies: Researchers explore ways to teach approved drugs new tricks
8. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
9. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
10. Pennsylvania American Waters Rate Case Approved
11. RNs Statement on Death of Nataline Sarkisyan: CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Girl Scouts of Historic Georgia and Peach State ... Girl Scout "Be a Friend First" program. Representatives from Peach State Health Plan presented ... State Health Plan and our parent company, Centene Corporation, are dedicated to raising anti-bullying ...
(Date:7/31/2015)... Seattle, WA (PRWEB) , ... July 31, 2015 , ... ... rapidly transforming the way we treat aging diseases. , BioViva announces it has ... to treat patients with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant ...
(Date:7/31/2015)... ... , ... The Heart Fit Clinic has increased a patient's fitness level 60 ... 150 beats versus 100 beats, this is a big deal," says Diamond Fernandes, director ... to patients with heart disease," he adds. People with angina are able to do ...
(Date:7/31/2015)... York, NY (PRWEB) , ... July 31, 2015 , ... ... kidney disease, according to a study published today in Nature Communications and led by ... conducted in mice, suggests that variations in the gene RTN1 led to greater production ...
(Date:7/31/2015)... ... , ... Indosoft, Inc., is pleased to announce a major update to its ... contact center ACD system for Asterisk-based call centers . The new features make ... to the agent only when wanted, and allows for validation of data as the ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2
... has issued a warning to leave no stone unturned to ... health department found, nearly 20%// of the children under 12 ... snacks on a daily basis. Healthy options like fruits ... ,The Health Minister, John Hill, said "We're working with ...
... New research has been released by Australian obesity experts that ... the international conference on obesity in Sydney there were three ... cent reduction in mortality rates in obese people who had ... around the upper part of the stomach for the procedure ...
... A team of surgeons at Children's National Medical Centre ... conjoined twins who shared a spinal cord and were// ... reported that Mateo and McHale Shaw from Sheboygan, Wisconsin ... 12 hours into Wednesday night. The hospital authorities had ...
... that men have a 4- to 5-point IQ advantage over ... on 100,000 17- to 18-year-//olds on the Scholastic Assessment Test ... is not obvious because girls mature faster than boys. This ... years. ,145 items from the SAT were examined ...
... is not rude but on the contrary would improve concentration.// ... Stirling in Scotland, led by Gwyneth Doherty-Sneddon have concluded in ... British Journal of Developmental Psychology, that looking away or gazing ... ,In the study that was conducted on a ...
... a week might reduce the risk of heart disease significantly.// ... Cardiology stated that as little as two servings of eight grams ... reduce the risk of heart disease by as much as 11%. ... the same kinds of nuts five days a week only results ...
Cached Medicine News:Health News:Successfully Separated Conjoined Twins In A Critical Yet Stable Condition 2Health News:Greater g factor in men responsible for sex differences in general mental ability 2Health News:Greater g factor in men responsible for sex differences in general mental ability 3
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
(Date:7/30/2015)... , July 30, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Biosensors Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) Explore ...
(Date:7/30/2015)... July 30, 2015 Takeda Pharmaceutical Company ... to fulfill the post-marketing commitment and submissions of ... European Multi-Database Bladder Cancer Risk Characterization Study , ... study, conducted in four European countries, for pioglitazone ... to 10 years of follow-up. Findings demonstrate that ...
Breaking Medicine Technology:Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... BIEL), the maker of inexpensive, disposable drug-free topical pain ... of an article in the peer reviewed journal ... The article documents the clinical trial results of ... Plantar fasciitis, or heel pain, is a ...
... 19, 2012 According to Marcia Crosse (Director, Health Care ... to protect American health has been compromised. In her comments ... High-Risk List, she says : "The ... the health of all Americans. FDA,s role is far-reaching: from ...
Cached Medicine Technology:BioElectronics' Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery 2Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 2Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 3Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 4
Indications For Usage: , Emergency use. , When medicant during ventilation is required. ...
... Indications For Usage: ... ,The monitoring lumen is ... of tracheal gases especially end-tidal ... pressure. , Introducing medication. ...
Indications For Usage: ,Laser surgery of the larynx or other areas in close proximity to the tracheal tube using CO2 or KTP laser beam....
Indications For Usage: ,Airway management during pediatric surgical procedures and intensive care....
Medicine Products: